미국 - 영어 - NLM (National Library of Medicine)

alcon laboratories, inc - travoprost (unii: wj68r08kx9) (travoprost - unii:wj68r08kx9) - travoprost 0.04 mg in 1 ml - travatan z® (travoprost ophthalmic solution) 0.004% is indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. none. risk summary there are no adequate and well-controlled studies in pregnant women to inform a drug-associated risk. in animal reproduction studies, subcutaneous (sc) administration of travoprost to pregnant mice and rats throughout the period of organogenesis produced embryo-fetal lethality, spontaneous abortion, and premature delivery at potentially clinically relevant doses. advise pregnant women of a potential risk to a fetus. because animal reproductive studies are not always predictive of human response, travatan z should be administered during pregnancy only if the potential benefit justifies the potential risk to the fetus. the background risk of major birth defects and miscarriage for the indicated population is unknown; however, in the u.s. general population, the estimated background risk of major birth defects is

몰타 - 영어 - Medicines Authority

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - travoprost - eye drops, solution - travoprost 40 µg - ophthalmologicals

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - travoprost -

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

bipharma b.v. - travoprost 0,04 mg/ml - eye drops, solution - 40 µg/ml - travoprost 0.04 mg/ml - travoprost

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - travoprost 0,04 mg/ml - eye drops, solution - 40 µg/ml - travoprost 0.04 mg/ml - travoprost

벨기에 - 영어 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - travoprost 0,004 % v/v - 100 % v/v - eye drops, solution - 40 µg/ml - travoprost 0.04 mg/ml - travoprost

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - timolol maleate,travoprost -

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - travoprost 40 µg/ml - eye drops, solution - 40 mcg/ml - active: travoprost 40 µg/ml excipient: benzalkonium chloride boric acid disodium edetate 1 m sodium hydroxide/1 m hydrochloric acid (ph 5.8-6.2) mannitol polyethylene glycol hydrogenated castor oil purified water trometamol - dp-travoprost eye drops are indicated to decrease elevated intraocular pressure in ocular hypertension and open-angle glaucoma as monotherapy or as adjunctive therapy.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - travoprost, quantity: 40 microgram/ml - eye drops, solution - excipient ingredients: boric acid; ethoxylated hydrogenated castor oil; polyquaternium-1; sodium hydroxide; mannitol; hydrochloric acid; propylene glycol; purified water; sodium chloride - travatan eye drops are indicated to decrease elevated intraocular pressure in: - ocular hypertension. - open-angle glaucoma. travatan eye drops may be used: - as first line monotherapy. - as adjunctive therapy.

이스라엘 - 영어 - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - travoprost - ophthalmic solution - travoprost 0.04 mg/ml - travoprost - for the reduction of elevated intra ocular pressure in patients with open-angle glaucoma or ocular hypertension who are intolerant of other iop lowering medications or insufficiently responsive to another iop lowering medication